Overview
Gopal Sachdeva is a Radiation Oncologist in Emeryville, California. Dr. Sachdeva is highly rated in 1 condition, according to our data. His top areas of expertise are Breast Cancer, Nasopharyngeal Carcinoma, Intraductal Papilloma, and Throat Cancer.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- MEDICARE MAPD
- MEDICARE SNP
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1480 64th St, Suite 100, Emeryville, CA 94608
Adult Neurofibromatosis Type 1 (NF1) And Schwannomatosis Clinic
Dr. David Raleigh is a radiation oncologist who specializes in brain tumors. He cares for both adult and pediatric patients. Raleigh's research focuses on understanding the biological processes that cause brain tumors to grow. His goals are to uncover new measures of brain cancer and to identify cells for drugs to target. Raleigh earned a bachelor's degree in molecular and cell biology as well as a bachelor's degree in cognitive science from the University of California, Berkeley. He earned his doctoral degree in molecular pathogenesis – how disease develops at the molecular level – from the University of Chicago, followed by his medical degree from the Pritzker School of Medicine at the University of Chicago. He completed a residency in radiation oncology at UCSF. Raleigh is a member of the American Society of Clinical Oncology, American Society for Radiation Oncology, Pacific Pediatric Neuro-Oncology Consortium, Children's Oncology Group, Society for Neuro-Oncology, International Meningioma Society and North American Skull Base Society. At the UCSF Brain Tumor Center, Raleigh is a principal investigator with the Wolfe Meningioma Program Project. Dr. Raleigh is highly rated in 22 conditions, according to our data. His top areas of expertise are Meningioma, Pineocytoma, Brain Tumor, and Gliomatosis Cerebri.
Stanford Health Care
Richard Hoppe is a Radiation Oncologist in Stanford, California. Dr. Hoppe is highly rated in 15 conditions, according to our data. His top areas of expertise are Hodgkin Lymphoma, Mycosis Fungoides, Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL), and Cutaneous T-Cell Lymphoma (CTCL).
Melanoma & Skin Cancer Center
Dr. Sue Yom is an expert in the radiation treatment and management of head, neck and lung cancers. In her research, Yom studies chemoradiation (a combination of chemotherapy and radiation) for these cancers. She also investigates image-guided radiation therapy and ways to reduce toxic effects using focused radiation techniques, emerging biological agents and radiation protectants. Yom earned her medical and doctoral degrees at the University of Pennsylvania. She completed a residency in radiation oncology at the MD Anderson Cancer Center. Yom has received numerous awards recognizing her commitment to patient care and patient-oriented research. Dr. Yom is highly rated in 28 conditions, according to our data. Her top areas of expertise are Nasopharyngeal Carcinoma, Head and Neck Squamous Cell Carcinoma (HNSCC), Merkel Cell Carcinoma, and Olfactory Neuroblastoma.
Frequently Asked Questions about Dr. Gopal Sachdeva
How do I make an appointment with Dr. Gopal Sachdeva?
You can book an appointment with Dr. Gopal Sachdeva by calling their office at 510-629-6682. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Gopal Sachdeva a top-rated expert for Breast Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Gopal Sachdeva is classified as an Distinguished expert for Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Gopal Sachdeva specialize in?
While Dr. Gopal Sachdeva is a Radiation Oncology, they have specific expertise in Breast Cancer, Nasopharyngeal Carcinoma, and Intraductal Papilloma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Radiation Oncology.
Does Dr. Gopal Sachdeva accept my insurance?
Dr. Gopal Sachdeva accepts most major insurance plans, including Aetna and Alignment Health Plan. We recommend calling the office directly at 510-629-6682 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Breast CancerDr. Sachdeva isDistinguished. Learn about Breast Cancer.
- Experienced
- AngiosarcomaDr. Sachdeva isExperienced. Learn about Angiosarcoma.
- Endometrial CancerDr. Sachdeva isExperienced. Learn about Endometrial Cancer.
- Endometrial Stromal SarcomaDr. Sachdeva isExperienced. Learn about Endometrial Stromal Sarcoma.
- Familial Prostate CancerDr. Sachdeva isExperienced. Learn about Familial Prostate Cancer.
- Fibrolamellar CarcinomaDr. Sachdeva isExperienced. Learn about Fibrolamellar Carcinoma.
- HER-2 Positive Breast CancerDr. Sachdeva isExperienced. Learn about HER-2 Positive Breast Cancer.

